Keywords:
Antibacterial agents; therapeutic use; cochlear implants; microbiology; pneumococcal vaccines; prosthesis-related infections; staphylococcal infections
Abstract:
With cochlear implantation becoming increasingly performed worldwide, an understanding of the risk factors, preventive measures, and management of cochlear implant (CI) infection remains important given the significant morbidity and cost it conveys.